» Articles » PMID: 15834465

Solid Lipid Nanoparticles As Drug Delivery Systems

Overview
Publisher Thomson Reuters
Specialty Pharmacology
Date 2005 Apr 19
PMID 15834465
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

For a decade, trials have been made to utilize solid lipid nanoparticles (SLNs) as alternative drug delivery systems to colloidal drug delivery systems such as lipid emulsions, liposomes, and polymeric nanoparticles. Various lipid matrices, surfactants, and other excipients used in formulation, preparation methods, sterilization and lyophilization of SLNs are discussed in this article. Entrapment efficiency of drug carrier and its effect on physical parameters, drug release, and release mechanisms of various compositions are reviewed and discussed. Important points in characterization and stability of SLNs are outlined. Various in vitro studies carried out by different research groups are mentioned in addition to in vivo evaluation. Exploitation potential of SLNs to administer by various routes of administration are covered. Passive and active drug targeting using SLNs are presented.

Citing Articles

Formulation Design, Optimization, and Evaluation of Solid Lipid Nanoparticles Loaded With an Antiviral Drug Tenofovir Using Box-Behnken Design for Boosting Oral Bioavailability.

M S, S S Adv Pharmacol Pharm Sci. 2025; 2024():5248746.

PMID: 39781028 PMC: 11707065. DOI: 10.1155/2024/5248746.


Fabrication and application of targeted ciprofloxacin nanocarriers for the treatment of chronic bacterial prostatitis.

Mohammad S, Aldosari B, Mehanni M, El-Gendy A, Hozayen W, Afzal O Int J Pharm X. 2024; 7:100247.

PMID: 38706465 PMC: 11066576. DOI: 10.1016/j.ijpx.2024.100247.


Third Generation Solid Dispersion-Based Formulation of Novel Anti-Tubercular Agent Exhibited Improvement in Solubility, Dissolution and Biological Activity.

Paudwal G, Dolkar R, Perveen S, Sharma R, Pal Singh P, Gupta P AAPS J. 2024; 26(3):52.

PMID: 38649550 DOI: 10.1208/s12248-024-00922-w.


Progress in the Treatment of Central Nervous System Diseases Based on Nanosized Traditional Chinese Medicine.

Li J, Long Q, Ding H, Wang Y, Luo D, Li Z Adv Sci (Weinh). 2024; 11(16):e2308677.

PMID: 38419366 PMC: 11040388. DOI: 10.1002/advs.202308677.


Development and optimization of vildagliptin solid lipid nanoparticles loaded ocuserts for controlled ocular delivery: A promising approach towards treating diabetic retinopathy.

Hakim Ramadan A, Elsayed M, Elsayed A, Fouad M, Mohamed M, Lee S Int J Pharm X. 2024; 7:100232.

PMID: 38357578 PMC: 10864762. DOI: 10.1016/j.ijpx.2024.100232.